IOVANCE BIOTHERAPEUTICS, INC. Share-based Payment Arrangement, Expensed and Capitalized, Amount
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Share-based Payment Arrangement, Expensed and Capitalized, Amount of $11.73 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Expensed and Capitalized, Amount
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 · last filed 2026-08-06
- IOVANCE BIOTHERAPEUTICS, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2026-06-30 was $11.73M, a 21.48% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2026-03-31 was $11.27M, a 50.82% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2025-12-31 was $11.82M, a 61.85% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2025-09-30 was $11.90M, a 61.62% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. share-based payment arrangement, expensed and capitalized, amount for fiscal 2025 was $61.58M, a 43.83% decline from fiscal 2024.
- IOVANCE BIOTHERAPEUTICS, INC. share-based payment arrangement, expensed and capitalized, amount for fiscal 2024 was $109.62M, a 75.05% increase from fiscal 2023.
- IOVANCE BIOTHERAPEUTICS, INC. share-based payment arrangement, expensed and capitalized, amount for fiscal 2023 was $62.63M, a 25.47% decline from fiscal 2022.
- IOVANCE BIOTHERAPEUTICS, INC. share-based payment arrangement, expensed and capitalized, amount for fiscal 2022 was $84.02M, a 20.44% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expensed and Capitalized, Amount 3 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 3 month as first filed | Share-based Payment Arrangement, Expensed and Capitalized, Amount 6 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 9 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 9 month as first filed | Share-based Payment Arrangement, Expensed and Capitalized, Amount 12 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $11.73M 10-Q · filed 2026-08-06 | $23.00M 10-Q · filed 2026-08-06 | $34.82M derived: sum of 3 quarters · filed 2026-08-06 | $46.72M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $11.27M 10-Q · filed 2026-05-07 | $23.09M derived: sum of 2 quarters · filed 2026-05-07 | $34.99M derived: sum of 3 quarters · filed 2026-05-07 | $49.93M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $11.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $23.72M derived: sum of 2 quarters · filed 2026-02-24 | $38.66M derived: sum of 3 quarters · filed 2026-08-06 | $61.58M 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $11.90M 10-Q · filed 2025-11-06 | $26.84M derived: sum of 2 quarters · filed 2026-08-06 | $49.76M 10-Q · filed 2025-11-06 | $80.73M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $14.94M 10-Q · filed 2026-08-06 | $37.86M 10-Q · filed 2026-08-06 | $68.83M derived: sum of 3 quarters · filed 2026-08-06 | $99.84M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $22.91M 10-Q · filed 2026-05-07 | $53.89M derived: sum of 2 quarters · filed 2026-05-07 | $84.89M derived: sum of 3 quarters · filed 2026-05-07 | $115.36M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $30.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $61.98M derived: sum of 2 quarters · filed 2026-02-24 | $92.44M derived: sum of 3 quarters · filed 2026-02-24 | $109.62M 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $31.01M 10-Q · filed 2025-11-06 | $61.47M derived: sum of 2 quarters · filed 2025-11-06 | $78.65M 10-Q · filed 2025-11-06 | $93.05M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-06-30 | $30.47M 10-Q · filed 2025-08-07 | $47.64M 10-Q · filed 2025-08-07 | $62.04M derived: sum of 3 quarters · filed 2026-02-24 | $77.86M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-03-31 | $17.18M 10-Q · filed 2025-05-08 | $31.58M derived: sum of 2 quarters · filed 2026-02-24 | $47.40M derived: sum of 3 quarters · filed 2026-02-24 | $64.14M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2023-12-31 | $14.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $30.22M derived: sum of 2 quarters · filed 2026-02-24 | $46.96M derived: sum of 3 quarters · filed 2026-02-24 | $62.63M 10-K · filed 2026-02-24 | |||
| 2023-09-30 | $15.82M 10-Q · filed 2024-11-07 | $32.56M derived: sum of 2 quarters · filed 2024-11-07 | $48.23M 10-Q · filed 2024-11-07 | $67.73M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | $16.74M 10-Q · filed 2024-08-08 | $32.41M 10-Q · filed 2024-08-08 | $51.91M derived: sum of 3 quarters · filed 2025-02-27 | $71.69M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | $15.66M 10-Q · filed 2024-05-09 | $35.17M derived: sum of 2 quarters · filed 2025-02-27 | $54.95M derived: sum of 3 quarters · filed 2025-02-27 | $77.42M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $19.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $39.29M derived: sum of 2 quarters · filed 2025-02-27 | $61.76M derived: sum of 3 quarters · filed 2025-02-27 | $84.02M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $19.78M 10-Q · filed 2023-11-07 | $42.25M derived: sum of 2 quarters · filed 2023-11-07 | $64.51M 10-Q · filed 2023-11-07 | $83.62M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-06-30 | $22.47M 10-Q · filed 2023-08-08 | $44.73M 10-Q · filed 2023-08-08 | $63.84M derived: sum of 3 quarters · filed 2024-02-28 | $83.14M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-03-31 | $22.27M 10-Q · filed 2023-05-10 | $41.37M derived: sum of 2 quarters · filed 2024-02-28 | $60.67M derived: sum of 3 quarters · filed 2024-02-28 | $75.09M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2021-12-31 | $19.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $38.41M derived: sum of 2 quarters · filed 2024-02-28 | $52.82M derived: sum of 3 quarters · filed 2024-02-28 | $69.77M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | $19.31M 10-Q · filed 2022-11-03 | $33.72M derived: sum of 2 quarters · filed 2022-11-03 | $50.66M 10-Q · filed 2022-11-03 | $60.89M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | $14.41M 10-Q · filed 2022-08-04 | $31.36M 10-Q · filed 2022-08-04 | $41.59M derived: sum of 3 quarters · filed 2023-02-28 | $52.29M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-03-31 | $16.94M 10-Q · filed 2022-05-05 | $27.17M derived: sum of 2 quarters · filed 2023-02-28 | $37.88M derived: sum of 3 quarters · filed 2023-02-28 | $48.42M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $10.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $20.94M derived: sum of 2 quarters · filed 2023-02-28 | $31.48M derived: sum of 3 quarters · filed 2023-02-28 | $40.89M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $10.71M 10-Q · filed 2021-11-04 | $21.24M derived: sum of 2 quarters · filed 2021-11-04 | $30.66M 10-Q · filed 2021-11-04 | $36.06M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | $10.54M 10-Q · filed 2021-08-05 | $19.95M 10-Q · filed 2021-08-05 | $25.36M derived: sum of 3 quarters · filed 2022-02-24 | $31.95M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | $9.41M 10-Q · filed 2021-05-06 | $14.82M derived: sum of 2 quarters · filed 2022-02-24 | $21.42M derived: sum of 3 quarters · filed 2022-02-24 | $27.84M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | $5.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $12.01M derived: sum of 2 quarters · filed 2022-02-24 | $18.43M derived: sum of 3 quarters · filed 2022-02-24 | $24.28M 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $6.60M 10-Q · filed 2020-11-05 | $13.02M derived: sum of 2 quarters · filed 2020-11-05 | $18.87M 10-Q · filed 2020-11-05 | $24.05M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | $6.43M 10-Q · filed 2020-08-06 | $12.27M 10-Q · filed 2020-08-06 | $17.46M derived: sum of 3 quarters · filed 2021-02-25 | $22.97M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | $5.85M 10-Q · filed 2020-05-05 | $11.03M derived: sum of 2 quarters · filed 2021-02-25 | $16.55M derived: sum of 3 quarters · filed 2021-02-25 | $21.77M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | $5.18M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $10.70M derived: sum of 2 quarters · filed 2021-02-25 | $15.92M derived: sum of 3 quarters · filed 2021-02-25 | $20.03M 10-K · filed 2021-02-25 | $20.03K 10-K · filed 2019-02-28 | ||
| 2018-09-30 | $5.52M 10-Q · filed 2019-11-04 | $10.74M derived: sum of 2 quarters · filed 2019-11-04 | $14.84M 10-Q · filed 2019-11-04 | $17.60M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-06-30 | $5.22M 10-Q · filed 2019-08-01 | $9.33M 10-Q · filed 2019-08-01 | $12.09M derived: sum of 3 quarters · filed 2020-02-25 | $14.71M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-03-31 | $4.10M 10-Q · filed 2019-05-07 | $6.86M derived: sum of 2 quarters · filed 2020-02-25 | $9.48M derived: sum of 3 quarters · filed 2020-02-25 | $12.78M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | $2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $5.38M derived: sum of 2 quarters · filed 2020-02-25 | $8.67M derived: sum of 3 quarters · filed 2020-02-25 | $11.97M 10-K · filed 2020-02-25 | |||
| 2017-09-30 | $2.62M 10-Q · filed 2018-11-06 | $5.91M derived: sum of 2 quarters · filed 2018-11-06 | $9.21M 10-Q · filed 2018-11-06 | -$6.55M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-06-30 | $3.29M 10-Q · filed 2018-08-07 | $6.59M 10-Q · filed 2018-08-07 | -$9.17M derived: sum of 3 quarters · filed 2019-02-28 | -$528.10K derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-03-31 | $3.30M 10-Q · filed 2018-05-10 | -$12.47M derived: sum of 2 quarters · filed 2019-02-28 | -$3.82M derived: sum of 3 quarters · filed 2019-02-28 | $1.54M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2016-12-31 | -$15.76M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$7.12M derived: sum of 2 quarters · filed 2019-02-28 | -$1.76M derived: sum of 3 quarters · filed 2019-02-28 | $18.90K 10-K · filed 2019-02-28 | $18.90M 10-K · filed 2017-03-09 | ||
| 2016-09-30 | $8.64M 10-Q · filed 2017-11-02 | $14.00M derived: sum of 2 quarters · filed 2017-11-02 | $15.78M 10-Q · filed 2017-11-02 | $18.53M derived: sum of 4 quarters · filed 2018-03-12 | |||
| 2016-06-30 | $5.36M 10-Q · filed 2017-08-03 | $7.14M 10-Q · filed 2017-08-03 | $9.88M derived: sum of 3 quarters · filed 2018-03-12 | $12.27M derived: sum of 4 quarters · filed 2018-03-12 | |||
| 2016-03-31 | $1.78M 10-Q · filed 2017-05-03 | $4.52M derived: sum of 2 quarters · filed 2018-03-12 | $6.91M derived: sum of 3 quarters · filed 2018-03-12 | $8.84M derived: sum of 4 quarters · filed 2018-03-12 | |||
| 2015-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $5.13M derived: sum of 2 quarters · filed 2018-03-12 | $7.06M derived: sum of 3 quarters · filed 2018-03-12 | $8.52M 10-K · filed 2018-03-12 | |||
| 2015-09-30 | $2.39M 10-Q · filed 2016-11-04 | $2.39M 10-Q · filed 2015-11-06 | $4.31M derived: sum of 2 quarters · filed 2016-11-04 | $5.78M 10-Q · filed 2016-11-04 | $5.78M 10-Q · filed 2015-11-06 | $6.87M derived: sum of 4 quarters · filed 2017-03-09 | |
| 2015-06-30 | $1.92M 10-Q · filed 2016-08-09 | $3.39M 10-Q · filed 2016-08-09 | $4.48M derived: sum of 3 quarters · filed 2017-03-09 | $5.42M derived: sum of 4 quarters · filed 2017-03-09 | |||
| 2015-03-31 | $1.47M 10-Q · filed 2016-05-09 | $2.56M derived: sum of 2 quarters · filed 2017-03-09 | $3.50M derived: sum of 3 quarters · filed 2017-03-09 | ||||
| 2014-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $2.03M derived: sum of 2 quarters · filed 2017-03-09 | $3.81M 10-K · filed 2017-03-09 | ||||
| 2014-09-30 | $940.00K 10-Q · filed 2015-11-06 | $2.72M 10-Q · filed 2015-11-06 | |||||
| 2013-12-31 | $2.75M 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |